Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alpha IVF Group BhdXKLS:0303 -2.00%54 3-Year EBITDA Growth Rate is 6.30% as of May. 2026, which is 87% below its 10-year median of 49.80. GuruFocus rates XKLS:0303 with a GF Score™ of 54/100. The stock has 2 warning signs investors should review. Among 525 Healthcare Providers & Services companies, Alpha IVF Group Bhd ranks worse than 57.71% on this metric.
During the past 12 months, Alpha IVF Group Bhd's average EBITDA Per Share Growth Rate was 5.90% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 6.30% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 38.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Alpha IVF Group Bhd was 78.30% per year. The lowest was 6.30% per year. And the median was 49.80% per year.
Alpha IVF Group Bhd (XKLS:0303) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Alpha IVF Group Bhd 3-Year EBITDA Growth Rate Related Terms
XKLS:0303 vs HCA, THC, EHC: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Alpha IVF Group Bhd's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha IVF Group Bhd 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alpha IVF Group Bhd's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Alpha IVF Group Bhd's 3-Year EBITDA Growth Rate falls into.
Alpha IVF Group Bhd 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 6.30% mean?
Alpha IVF Group Bhd (XKLS:0303) has a 3-Year EBITDA Growth Rate of 6.30% as of May. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Alpha IVF Group Bhd and its competitors. This is 87% below median its historical median of 49.80. Over the past decade, Alpha IVF Group Bhd's 3-Year EBITDA Growth Rate has ranged from 6.30 to 78.30. According to the industry distribution chart, Alpha IVF Group Bhd ranks #303 out of 525 companies in the Healthcare Providers & Services industry, placing it in the top 57.7%.
Is Alpha IVF Group Bhd's 3-Year EBITDA Growth Rate too high?
Alpha IVF Group Bhd's current 3-Year EBITDA Growth Rate of 6.30% is 87% below median its 10-year median of 49.80. Over the past 10 years, this metric has ranged from a low of 6.30 to a high of 78.30. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 9.90. Alpha IVF Group Bhd's value of 6.30% is 36.4% below this industry median. Based on the distribution chart, Alpha IVF Group Bhd ranks #303 out of 525 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Alpha IVF Group Bhd has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Alpha IVF Group Bhd's 3-Year EBITDA Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Alpha IVF Group Bhd ranks #303 out of 525 companies for 3-Year EBITDA Growth Rate. This places Alpha IVF Group Bhd in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 9.90. Alpha IVF Group Bhd's value of 6.30% is 36.4% below this benchmark. Historically, Alpha IVF Group Bhd's own 3-Year EBITDA Growth Rate has ranged from 6.30 to 78.30 over the past decade. While the company's 10-year median is 49.80 vs. the industry median of 9.90, Alpha IVF Group Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 9.90, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha IVF Group Bhd's current 3-Year EBITDA Growth Rate of 6.30% is 36.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Alpha IVF Group Bhd and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 9.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha IVF Group Bhd's current 3-Year EBITDA Growth Rate is 6.30%, which is 87% below median its own 10-year median of 49.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha IVF Group Bhd stock overvalued right now?
Alpha IVF Group Bhd (XKLS:0303) has a current 3-Year EBITDA Growth Rate of 6.30%. The current 3-Year EBITDA Growth Rate is 6.30%, which is 87% below median its 10-year median of 49.80 and 36.4% below the Healthcare Providers & Services industry median of 9.90. Alpha IVF Group Bhd's overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Alpha IVF Group Bhd (XKLS:0303), the current 3-Year EBITDA Growth Rate is 6.30% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alpha IVF Group Bhd is a fertility care specialist focusing on assisted reproductive services in Malaysia, Singapore, Indonesia, and China, with the majority of its revenue coming from Malaysia. Assisted reproductive services is a general term that includes all types of fertility treatments and procedures to help people facing difficulties in getting pregnant. The company offers a range of assisted reproductive services such as IVF to assist patients with infertility conditions in achieving clinical pregnancy. It also provides other procedures including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), various diagnostic, testing, and screening procedures, as well as cryopreservation of eggs, sperm, and embryos.
54GF Score
Get the complete analysis for XKLS:0303
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0303 has been successfully added to your 
